W. G. Ross

Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes.

Craig L. Slingluff, Galina V. Yamshchikov, Patrice Y. Neese et al. · PubMed · 2001 · 229 citations

Medicine, Immunology, Oncology +17

A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence

Mohammad Samiul Alam, Courtney C. Kurtz, Jeffrey M. Wilson et al. · Mucosal Immunology · 2009 · 77 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.

Galina V. Yamshchikov, Ladaisha Thompson, W. G. Ross et al. · PubMed · 2001 · 42 citations

Life Sciences, Immunology, Oncology +17

TGF-beta 1 causes increased endothelial ICAM-1 expression and lung injury

Yukio Suzuki, Toshimori Tanigaki, Dov Heimer et al. · Journal of Applied Physiology · 1994 · 39 citations

Life Sciences, Immunology, Pathology +17

Attenuation of acute lung injury and oxygen radical production by the 21-aminosteroid, U-78518F

Toshimori Tanigaki, Yasuhiro Suzuki, Dov Heimer et al. · Journal of Applied Physiology · 1993 · 16 citations

Life Sciences, Biochemistry, Pharmacology +16